Merck (MRK) Prepaid Assets (2009 - 2026)
Merck's (MRK) quarterly Prepaid Assets came in at $10.8 billion in Q2 2026, up 7.71% year-over-year from $10.0 billion in Q2 2025, and up 1.35% quarter-over-quarter from $10.6 billion in Q1 2026.
Analysis
Merck (MRK) Prepaid Assets (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Prepaid Assets for 16 consecutive years, with $10.8 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 7.71% year-over-year to $10.8 billion in Q2 2026; TTM through Jun 2026 was $10.8 billion, a 7.71% increase from a year earlier, with the FY2025 full-year figure at $10.5 billion, up 20.81% from the prior year.
- Prepaid Assets was $10.8 billion for Q2 2026 at Merck, up from $10.6 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $10.8 billion in Q3 2025 and troughed at $6.7 billion in Q3 2023.
- A 5-year average of $9.1 billion and a median of $8.7 billion in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets gained 2.6% in 2022 and soared 32.37% in 2025, its largest moves.
- Over 5 years, Prepaid Assets stood at $7.2 billion in 2022, then increased by 16.72% to $8.4 billion in 2023, then increased by 4.04% to $8.7 billion in 2024, then grew by 20.81% to $10.5 billion in 2025, then grew by 2.37% to $10.8 billion in 2026.
- The last three Prepaid Assets figures came in at $10.8 billion (Q2 2026), $10.6 billion (Q1 2026), and $10.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.77 Bn |
| Mar 31, 2026 | 10.62 Bn |
| Dec 31, 2025 | 10.52 Bn |
| Sep 30, 2025 | 10.78 Bn |
| Jun 30, 2025 | 10.00 Bn |
| Mar 31, 2025 | 9.29 Bn |
| Dec 31, 2024 | 8.71 Bn |
| Sep 30, 2024 | 8.14 Bn |
| Jun 30, 2024 | 8.74 Bn |
| Mar 31, 2024 | 7.95 Bn |
| Dec 31, 2023 | 8.37 Bn |
| Sep 30, 2023 | 6.66 Bn |
| Dec 31, 2022 | 7.17 Bn |
| Dec 31, 2021 | 6.99 Bn |
| Dec 31, 2020 | 4.67 Bn |
| Dec 31, 2019 | 4.28 Bn |
| Dec 31, 2018 | 4.50 Bn |
| Dec 31, 2017 | 4.30 Bn |
| Dec 31, 2016 | 4.39 Bn |
| Dec 31, 2015 | 5.14 Bn |